Drug intelligence / Profile preview

Alcofiltrum

Development stage
Unknown
Lead developer
Avva Pharmaceuticals
Modality
Peptides, Small Molecules
Administration
Oral
01

Overview

Alcofiltrum is an orally administered dietary supplement formulated to alleviate the severity of alcohol hangover symptoms through the combined action of its key ingredients: lignin hydrolyzed, dihydromyricetin, glycine, and thiamine (vitamin B1)[1][3][5][7]. - **Lignin hydrolyzed** is a plant-derived insoluble dietary fiber with a high sorption capacity for various toxic substances, most notably acetaldehyde and fusel alcohols, which contribute to hangover symptoms[1][3][5]. It also exhibits antioxidant and water-holding properties. - **Dihydromyricetin** is a natural flavonoid extracted from hovenia dulcis that counteracts the effects of ethanol intoxication by antagonizing ethanol's action on neuron cells and provides antioxidant benefits[1][3][5]. - **Glycine** is an amino acid neurotransmitter supporting healthy nervous system function and may help in neutralizing toxic alcohol metabolites[1][3][5]. - **Thiamine (Vitamin B1)** supports normal energy metabolism, which can be affected during alcohol hangovers, and contributes to proper nervous system function[1][3][5]. Alcofiltrum is clinically tested and shown to reduce the severity of several hangover symptoms including headache, weakness, sleep disturbance, and impaired concentration[3][9]. It comes in tablet form, each containing 800 mg lignin hydrolyzed, 150 mg glycine, 30 mg dihydromyricetin, and 30 mg vitamin B1[3][5]. The product is manufactured under GMP pharmaceutical standards for quality control[2].

Brand names
Alcofiltrum
Other names
Alcofiltrum

Beyond the preview

Go deeper on Alcofiltrum.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alcofiltrum.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call